Nkarta, Inc.
NKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787400
No open-market purchases or sales by Nkarta, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Nkarta, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 104 | 120 | +16 |
| Shares | 58.4M | 57.7M | −680.2K (−1.2%) |
| Value | $96.9M | $119.4M | +$22.5M (+23.2%) |
New holders (24)
Institutions that held Nkarta, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (8)
Institutions that held Nkarta, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Affinity Asset Advisors, LLC | 800,000 | $1.33M |
| Thrivent Financial for Lutherans | 63,143 | $105.0K |
| ProShare Advisors LLC | 13,617 | $22.6K |
| Holistic Planning, LLC | 10,450 | $17.3K |
| Mercer Global Advisors Inc | 10,082 | $16.7K |
| Raymond James Financial Inc | 8,692 | $14.4K |
| Caitong International Asset Management Co., Ltd | 6,091 | $10.1K |
| Clearstead Advisors, LLC | 11 | $19 |